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Summary
Thymidylate synthase (TS) is an E2F1-regulated enzyme that is essential for DNA synthesis and repair. TS protein and
mRNA levels are elevated in many human cancers, and high TS levels have been correlated with poor prognosis in patients
with colorectal, breast, cervical, bladder, kidney, and non-small cell lung cancers. In this study, we show that ectopic
expression of catalytically active TS is sufficient to induce a transformed phenotype in mammalian cells as manifested by
foci formation, anchorage independent growth, and tumor formation in nude mice. In contrast, comparable levels of two
TS mutants carrying single point mutations within the catalytic domain had no transforming activity. In addition, we show
that overexpression of TS results in apoptotic cell death following serum removal. These data demonstrate that TS exhibits
oncogene-like activity and suggest a link between TS-regulated DNA synthesis and the induction of a neoplastic phenotype.
Introduction et al., 2003; Nomura et al., 2002). Whether TS overexpression
is a consequence of aberrant cellular proliferation or whether
overexpression of TS participates directly in stimulating the in-Thymidylate synthase (TS) plays a central role in the biosynthe-
sis of thymidylate, an essential precursor for DNA synthesis. TS crease in cell growth and proliferation associated with the trans-
formed phenotype remains to be established.catalyzes the reductive methylation of 2-deoxyuridine
5-monophosphate (dUMP) by transfer of a methylene group TS transcription is regulated by several protein factors, in-
cluding members of the E2F gene family (DeGregori et al., 1995;from a cofactor, CH2H4 folate, to generate deoxythymidine-5-
monophoshate (dTMP). dTMP is further phosphorylated to the Dong et al., 2000; Dyson, 1998; Trimarchi and Lees, 2002). The
importance of E2F function has been demonstrated by studiestriphosphate state (dTTP), which is a direct precursor for DNA
synthesis. Since the TS catalyzed reaction is the sole intracellu- which show that inhibition of E2F-1 prevents entry into S phase
(Wu et al., 1996) and that ectopic expression of E2F-1 in quies-lar de novo source of dTMP, the inhibition of TS results in
the cessation of cellular proliferation and growth (Friedkin and cent cells is sufficient for progression into DNA synthesis (John-
son et al., 1993). Overexpression of E2F-1 also results in cellularKornberg, 1957; Navalgund et al., 1980).
Several clinical studies have shown that TS protein and transformation of rodent cells (Singh et al., 1994; Xu et al., 1995).
In addition, it has been demonstrated that overexpression ofmRNA levels are higher in cervical, breast, kidney, bladder,
lung, and gastrointestinal tumor tissues than in their normal E2F-1 in both human fibrosarcoma cells and quiescent rat fi-
broblast cells results in an increase in TS mRNA and proteincounterparts and that high TS levels have been associated with
poor clinical outcome in these cancers (Johnston et al., 1995; levels (Banerjee et al., 1998; DeGregori et al., 1995), suggesting
that E2F-1 might play an important role in the regulation of TSLeichman, 2001; Mizutani et al., 2003; Nomura et al., 2002;
Pestalozzi et al., 1997; Shintani et al., 2003; Suzuki et al., 1999). gene expression in vivo. E2F-1 plays a central role in regulating
the transition from the G1 to S phase during cell cycle progres-Tumors with elevated TS levels are thought to undergo more
active cellular proliferation, which in turn is associated with sion (Wu et al., 1996) by serving as a bifunctional transcription
factor which can repress gene transcription when bound to thetumor invasiveness and metastasis (Edler et al., 2000; Mizutani
S I G N I F I C A N C E
Elevated levels of thymidylate synthase (TS) activity have been identified as an important prognostic biomarker for colorectal cancer
and for many other common human malignancies. A common interpretation for this observation has been that elevated levels of
TS protein arise simply as epiphenomena which are secondary to aberrant tumor cell proliferation. In this report, we have demonstrated
that ectopic expression of human TS can transform murine cells in vitro and in vivo, which instead infers a causal role for TS in
mammalian tumorigenesis. This data also suggests that regulating TS activity in vivo may be important for the development of both
cancer prevention and therapeutic strategies.
CANCER CELL : APRIL 2004 · VOL. 5 · COPYRIGHT  2004 CELL PRESS 341
A R T I C L E
retinoblastoma (RB) protein and other corepressor molecules
in nonmitotic cells (Cam and Dynlacht, 2003). In response to
external and internal growth signals, however, RB undergoes
conformational changes due to cyclin-mediated phosphoryla-
tion and is released from E2F-1 binding. Free E2F-1 binds to
DNA where it exhibits a transcriptional activation function that
appears to be critical for proper entry into S phase. Loss of RB
function, therefore, results in the constitutive induction of a set
of E2F-1 regulated genes that encode several DNA synthesis
enzymes, including TS, dihydrofolate reductase (DHFR), DNA
polymerase , and thymidine kinase (TK) (Helin, 1998). Overex-
pression of E2F-1 in rat embryo fibroblast, however, resulted
in a greater increase in TS as compared to DHFR and TK (Ban-
erjee et al., 1998), suggesting that the TS promoter activity
exhibits enhanced sensitivity to levels of E2F-1 activity and that
increased levels of TS may not be due solely to a general in-
crease in DNA synthesis enzymes.
Since E2F-1 overexpression leads to both cellular transfor-
Figure 1. Thymidylate synthase (TS) induced foci in NIH/3T3 cellsmation and the induction of TS expression (Singh et al., 1994),
A: Immunoblot analysis of cell extracts from stably transfected TS and controland since TS levels are elevated in malignant tissues (Gorlick
cell pools (lanes 3 and 4). The MCF-7 and NIH/3T3 cells represent positiveet al., 1998; Mizutani et al., 2003; Nomura et al., 2002; Shintani
and negative controls for the expression of human TS, respectively (laneset al., 2003; Suzuki et al., 1999), we tested whether TS might
1 and 2). The arrow depicts ectopic expression of human TS (hTS) detected
act as a downstream effector of E2F-1 to participate in the with TS106 monoclonal antibody.
oncogenic pathway. We found that overexpression of TS can B–D: Focus assays. NIH/3T3 cell pools transfected with the indicated plasmids
and tested at different passage numbers (p1, p3, and p8) for foci formation.result in neoplastic transformation and in programmed cell death
upon removal of survival factors.
Results
foci revealed multilayered growth and crisscross morphology
characteristic of transformed cells (data not shown). The numberOverexpression of thymidylate synthase induces
of foci in the TS-transfected cell pool was approximately 10-foldtransformed foci in NIH/3T3 cells
higher when tested at passage 8, demonstrating the selectiveTo determine whether overexpression of human thymidylate
advantage of transformed cells (Figure 1C). To confirm this ob-synthase could lead to cellular transformation, immortalized
servation, NIH/3T3 cells were transfected with a different TSNIH/3T3 mouse fibroblast cells were transfected with either a
expression vector, pCIneo-TS, containing the neomycin resis-TS expression plasmid (pcDNA3.1zeo-TS) or the empty control
tance gene or with the empty control vector, pCIneo. G418-vector (pcDNA3.1zeo). Stable zeocin-resistant clones were
resistant cell clones were pooled and tested for foci formationpooled and protein extracts from both the TS and vector-trans-
immediately without passage. We again found that overexpres-fected cell pools were analyzed by SDS-polyacrylamide gel
sion of TS gave rise to foci formation in NIH/3T3 cells, whileelectrophoresis (PAGE) using anti-TS antibody (Behan et al.,
transfection of the pCIneo vector had no effect (Figure 1D). This1998). The TS-transfected cell pool contained high levels of
data suggests that overexpression of TS in mammalian cells ishuman TS that could be resolved from the endogenous mouse
sufficient to induce foci with a dysplastic morphology in NIH/TS (Figure 1A). The difference in the electrophoretic mobility of
3T3 cells in vitro and that additional passaging of these cellsmouse and human TS was verified by the comparison of the
was not required for the acquisition of a transformed phenotype.migration pattern of TS in protein extracts obtained from human
MCF-7 breast cancer cells and mouse NIH/3T3 cells. The migra-
Neoplastic transformation inducedtion pattern displayed by the human TS that was ectopically
by thymidylate synthaseexpressed in transfected rodent NIH/3T3 cells was similar to
To establish whether overexpression of TS may result in a neo-the migration pattern exhibited by the endogenous human TS
plastic phenotype, single cell clones were isolated from NIH/in MCF-7 cells (Figure 1A, lanes 1 and 4), while the empty
3T3 cells transfected with either TS or the empty control vector.vector-transfected NIH/3T3 cells exhibited only low levels of
the endogenous mouse TS. Protein extracts isolated from each clone were tested for TS
expression by immunoblot analysis. Of the eleven TS-trans-To determine whether overexpression of TS results in a
transformed phenotype of the NIH/3T3 cells, we tested the abil- fected clones examined, seven expressed detectable exoge-
nous human TS protein (Figure 2A, lanes 3–9), while the humanity of TS-transfected cells to form foci in monolayer cultures.
Cells were selected in zeocin-containing medium to enrich for TS was absent in the empty control vector (Figure 2A, lane 2)
and in parental NIH/3T3 cells (Figure 2A, lanes 1 and 10).the transfected cells, and the foci assay was performed using
the third passage of pooled clones from either control or TS To determine whether the ectopically expressed human TS
retained catalytic activity in the NIH/3T3 mouse cells, we mea-transfected cells. We found that cells overexpressing human
TS gave rise to foci 4–6 weeks after inoculation, while no foci sured the conversion of dUMP to dTMP by a tritium release
assay (Allegra et al., 1985). We found that exogenously ex-were observed at 6 weeks in the cells transfected with the vector
control (Figure 1B). Microscopic examination of the TS-induced pressed human TS retained catalytic activity in mouse NIH/3T3
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Figure 2. In vitro transformation by thymidylate synthase (TS)
A: Expression of ectopic human thymidylate synthase (TS) in single cell clones derived from NIH/3T3 cells. Immunoblot analysis with anti-TS detects mouse
(mTS) and human (hTS) as indicated by the arrows in TS-expressing cell clones (lanes 3–9), vector alone (lane 2), parental cells (lanes 1 and 10), and the
control human MCF-1 cells (lane 11).
B: TS catalytic activity was measured in the indicated single cell clones. The TS protein control was purified from L. caseii. Results shown are mean  standard
deviation (SD) of three to four separate experiments.
C: Comparison of ectopic TS levels in NIH/3T3 cells to TS levels in human tumor cell lines. Immunoblot analysis detects TS and actin as indicated by the
arrows. TS and actin levels were measured using NIH image program.
D: Growth analysis of TS overexpressing cells. Growth curves of TS transfected cell lines (TS-c5, squares; TS-c7, triangles) compared to vector alone cells
(V-c1, circles; V-c2, diamonds). Results shown represent the average from triplicate plates.
E: Growth of thymidylate synthase-transformed cells in soft agar. Photomicrograph of representative agar clones from TS-overexpressing cells (TS-c7) and
vector control cells (V-c1).
F: Immunoblot analysis with anti-TS detects human TS in protein extracts isolated from agar clones. Single agar clones were isolated from two independent
TS-transfected clones, TS-c6 and TS-c7 (lanes 1–4). Protein extract from TSc-7 were used as a positive control for detection of human TS (hTS).
cells with up to a 20-fold increase in TS catalytic activity in cells lines (Figure 2C). We found that TS protein levels varied up to
50-fold between the different tumor lines, and that the levels oftransfected with human TS as compared to the empty vector
transfectants or to the parental NIH/3T3 cells (Figure 2B). In ectopic human TS in the mouse cell clone TS-c7 were intermedi-
ate within this range (7.5-fold lower than the cell line with theaddition, TS enzymatic activity directly correlated with the
amount of steady-state TS detected by immunoblot analysis highest steady-state TS/actin expression (CA46) and 6.5 fold
higher than the cell line with the lowest TS/actin expression(Figures 2A and 2B). Thus, the ectopically expressed human
TS maintained high steady-state levels of biological activity in [MCF-7]) (Figure 2C).
Morphological examination of the TS-overexpressing clonesmouse NIH/3T3 cells.
Since previous studies using immunoblotting or quantitative under light microscopy revealed a characteristic transformed
cell morphology. The TS transformants were small, refractile,PCR showed that TS protein content and RNA levels may vary
up to 60-fold in primary human colorectal cancer biopsies or and spindle shaped, and displayed multilayered growth. In con-
trast, the empty vector-transfected cells grew in a monolayercancer cell lines (Grem et al., 2001; Leichman, 2001), we per-
formed immunoblot analysis to compare the amount of TS pro- and morphologically resembled normal NIH/3T3 cells (data not
shown). TS-overexpressing cells lost contact inhibition, re-tein relative to endogenous actin levels in the transfected clone
TS-c7 with protein extracts from different types of tumor cell sulting in piling up and crisscrossing with a 2- to 3-fold increase
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Table 2. Tumor formation in Balb/c nude miceTable 1. Colony growth in soft agar
# of mice with tumors/# of mice injectedAverage number of
Latencyclones*
Total number % efficiency Cell line Exp 1 Exp 2 Exp 3 Total % (weeks)a
Cell line Small Large of clones in agar
V-c1 0/7 0/7 0/7 0/21 0
V-c3 b  0/6 0/6 0V-c1 16 0 16 0.016
V-c3 14 0 14 0.014 V-c4   0/4 0/4 0
TS-c5 7/7  7/7 14/14 100 6.5–9TS-c5 554 65 619 0.619
TS-c6 417 11 428 0.428 TS-c6 4/7 2/2 1/7 7/16 44 9–15
TS-c7 4/7 5/6 3/7 12/20 60 6.7–17TS-c7 714 52 766 0.766
a All animals were sacrificed at 23–24 weeks.1  105 cells were plated in 0.3% agar, 0.2% peptone, and DMEM supple-
mented with 1% Glutamine, 1% PenStrep, 15% FBS, 4 mM HEPES, and 400 b Not determined.
g zeocin per ml. Numbers refer to mean number of colonies per 60 mm
dishes (in triplicate) appearing in 14 days.
*Average of two to three separate experiments.
continued to demonstrate high levels of ectopic human TS as
determined by immunoblot analysis (data not shown). These
data suggest that TS overexpression renders NIH/3T3 cells tu-in saturation density as compared to the vector control culture
morigenic in vivo.(data not shown). In addition, comparison of the growth rates
of the TS-overexpressing clones, TS-c5 and TS-c7, to the empty
Catalytic activity of thymidylate synthase is requiredcontrol vectors, V-c1 and V-c2, demonstrated faster cell growth
for the establishment of neoplastic phenotypefor TS-overexpressing cells (Figure 2D). Three TS-overexpress-
Since TS is an essential S phase enzyme required for DNAing clones and two empty control vector clones were also tested
synthesis, we hypothesized that the catalytic activity of thefor the acquisition of colony formation in 0.3% soft agar, an in
enzyme may be necessary for its transforming ability. To testvitro parameter for the transformed phenotype. We found that
our hypothesis, we overexpressed TS mutants carrying pointall three ectopic TS-expressing cell lines, TS-c5, TS-c6, and TS-
mutations that result in the loss of catalytic activity of the en-c7, acquired an anchorage-independent phenotype and could
zyme. We used two distinct point mutants both located in thegrow in 0.3% agar. Clones TS-c5, TS-c6, and TS-c7 grew in
catalytically important and highly conserved Arg50-loop of TSsoft agar with a 25- to 50-fold increased efficiency as compared
(Schiffer et al., 1995). Overexpression of these two TS mutants,with the control cell lines V-c1 and V-c3 (Table 1). Agar clones
Arg50Cys and Thr51Ala, could not rescue growth of TS-negativederived from the TS-overexpressing cell lines designated as
cells in selective medium lacking thymidine as compared to“small” were approximately double the size of “small” clones
the wild-type enzyme (Tong et al., 1998). We subcloned TS-in the control culture, V-c1 and V-c3, and grew progressively
Arg50Cys and TS-Thr51Ala into the same expression vectorlarger after two weeks of incubation. Agar clones from the empty
(pcDNA3.1 zeo) that we used to express wild-type TS in ourcontrol vector line V-c1, however, were uniformly small and did
earlier transformation assays. Mutant and wild-type vectorsnot increase in size when left in culture longer than two weeks
were transfected into NIH/3T3 cells and single cell clones were(Figure 2E). Immunoblot analysis of extracts isolated from agar
isolated following zeocin selection. Protein extracts from eachclones established from TS-overexpressing cells reveal high
clone were tested for TS expression by immunoblot analysis.levels of TS protein (Figure 2F), demonstrating that cells that
Both mutant and wild-type TS-transfected cells expressed ex-grew in agar retained ectopic expression of human TS. These
ogenous human TS (Figure 3A, lanes 3 to 11), while the enzymeresults from both foci and soft agar assays suggest that overex-
was absent in the empty vector control (Figure 3A, lane 1).pression of TS is associated with cellular transformation in vitro.
Protein extract from clone TS-c7 was used as a positive controlTo determine whether overexpression of TS resulted in neo-
(Figure 3A, lane 2). To determine the catalytic activity of theseplastic transformation in vivo, we tested the ability of TS-overex-
mutants when expressed in NIH/3T3 cells, we selected cellpressing cells to form tumors in nude mice. We injected 5 
clones that expressed similar steady-state protein levels as106 cells from each of the TS-overexpressing cell lines, TS-c5,
shown by immunoblot analysis (Figure 3A) and measured theTS-c6, and TS-c7 subcutaneously into the back of five-week-
conversion of dUMP to dTMP by TS using an in vitro catalyticold athymic Balb/c mice and monitored for tumor growth. We
activity assay (Figure 3B, lanes 2 to 7). In addition, a proteinobserved that injection of the TS-overexpressing cell lines re-
sample isolated from a clone transfected with empty vector wassulted in tumor formation, whereas xenograft tumor growth was
used as a control to measure the catalytic activity of endogenousnot observed with control cells. The latency period for tumor
mouse TS (Figure 3B, lane 1). We found that the exogenouslyformation varied; however, tumors were first noticed at the injec-
expressed mutants TS-Arg50Cys (cell lines mTS-c3 and mTS-tion site at 6 weeks for the TS-c5 and TS-c7 clones and at 9
c5) and mutant TS-Thr51Ala (cell lines mTS-c6 and mTS-c7),weeks for the TS-c6 clone (Table 2). 100% of the TS-c5 injected
with similar levels of TS expression (Figure 3A), showed reducedmice developed tumors by 9 weeks, while 44% of the TS-c6
catalytic activity as compared to the wild-type TS (Figure 3B).injected mice developed tumors by 15 weeks and 60% of TS-
Thus, ectopically expressed human TS that contain a pointc7 injected animals developed tumors at 17 weeks following
mutation in the UTP-folate binding site maintains high steady-inoculation. In contrast, no tumors were observed at 24 weeks
state protein levels that lacks biological activity in NIH/3T3 cells.in mice injected with three independently derived vector control
To establish whether high levels of exogenously expressed,clones, V-c1, V-c3, and V-c4 (Table 2). Protein extracts of re-
sected xenograft tumors derived from TS-overexpressing cells catalytically inactive TS are capable of inducing transformation,
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Figure 4. In vitro transformation of rat kidney (RK3E) cells by thymidylate
synthase
A and B: Focus assays. RK3E cell pools transfected with the indicated plas-
Figure 3. Characterization of overexpressed mutants of human thymidylate mids were tested at passage 2 for foci formation.
synthase (TS) lacking catalytic activity of the enzyme C: Immunoblot analysis of cell extracts from pools of stably transfected
cells with empty vector (lane 1), wild-type TS (lane 2), and mutants TS,A: Expression of mutated human TS in single cell clones derived from NIH/
TS(Arg50Cys), and TS(Thr51Ala) (lanes 3 and 4). The TS-c7 cells represent a3T3 cells. Immunoblot analysis with anti-TS detects wild-type clones (TS-c7
positive control for the expression of human TS (lane 5), and the arrowsand TS-c8) and mutant TS clones (mTS-c1 to mTS-c8) in TS-expressing cells
depicts ectopic expression of human TS (hTS) or rat TS (rTS).(lanes 2–11). Vector control cell clone V-c2 is shown in lane 1. Mutations
D: TS catalytic activity was measured from the same extracts derivedfrom arginine to cysteine and from threonine to alanine at positions 50
from cell pools as described in C. Results shown are mean  SD of three(Arg50Cys) and 51 (Thr51Ala), respectively, are indicated.
experiments.B: Catalytic activity of mutated human thymidylate synthase (TS). TS cata-
lytic activity was measured in the indicated single cell clones. Results shown
are mean  SD of three experiments.
is sufficient to prevent neoplastic transformation induced by
biologically active TS in vivo.
we tested cell clones with overexpressed mutant TS for the
acquisition of in vitro and in vivo parameters of transformed Overexpression of catalytically active thymidylate
phenotype, including anchorage independent growth in soft synthase induces transformation in RK3E cells
agar and tumorigenicity in nude mice. We found that none of To test if thymidylate synthase can act as an oncogene and
the four cell lines expressing ectopic TS-Arg50C or TS-Thr51A transform other mammalian cells in addition to NIH/3T3, we
acquired anchorage independence for growth as compared to transfected the TS expression plasmid (pcDNA3.1zeo-TS) or
cell lines that overexpressed wild-type TS which could grow in control vector (pcDNAzeo) into E1A immortalized rat kidney
soft agar (Table 3). In addition, injection of 5  106 cells that
cells (RK3E). Stable clones were selected in zeocin-containing
overexpressed mutant TS did not give rise to tumors in Balb/c
medium, and foci assay was performed using second passage
nude mice by 24 weeks as compared to cells that overexpress
of pooled clones. We found that cells expressing human TSwild-type TS which developed tumors between 8 to 18 weeks
gave rise to foci three weeks after inoculation, while no fociin injected animals (Table 3). These data demonstrate that a
were observed in the cells transfected with the control vectorsingle point mutation that abolishes the catalytic activity of TS
(Figure 4A). In addition, we transfected RK3E cells with the
mutant TS expression plasmids (Arg50Cys and Thr51Ala). In
contrast to wild-type TS, foci formation was not observed in
RK3E cells transfected with the mutant enzymes (Figure 4B).Table 3. Mutation in the catalytic site of TS abolish oncogenic activity of
To demonstrate that the inability of these cells to form foci wasthe enzyme
linked to the absence of TS catalytic activity and not the absenceTumorgenicity (animals
of TS protein, protein extracts were obtained from the wild-% efficiency with tumors/animals
Cell line Mutation in soft agar injected)a type, mutant, and control vector-transfected RK3E cells and
analyzed by SDS-PAGE using anti-TS antibody. The TS(Arg50-TS-c7 Wild-type 0.5 7/10
mTS-c3 Arg-50Cys 0 0/7 Cys) and TS(Thr51Ala)-transfected cell pools contained high
mTS-c5 Arg-50Cys 0 0/7 levels of human TS that could be resolved from the endogen-
mTS-c6 Thr-51Ala 0 0/7
ous rat TS (Figure 4C). To confirm that TS(Arg50Cys) andmTS-c7 Thr-51Ala 0 0/5
TS(Thr51Ala) mutants lacked catalytic activity in RKE3 cells, we
a All animals were sacrificed at 24 weeks measured the conversion of dUMP to dTMP by a tritium release
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assay (Allegra et al., 1985). We found that exogenously ex- cells, V-c1, did not show appreciable proteolysis of PARP (Fig-
ure 5D, lanes 1–4).pressed TS mutants were catalytically inactive in mouse RKE3
cells (Figure 4D). These results demonstrate that wild-type TS Mechanisms described previously for oncogene-induced
apoptosis include activation of a mitochondrial pathway (whichcan induce transformation in two distinct mammalian cell lines
and confirm that catalytic activity of the enzyme is required for can be inhibited by Bcl-2 or Bcl-XL) and autocrine activation of
death receptors, such as Fas receptor (Hueber et al., 1997;the induction of oncogenic activity of TS.
Klefstrom et al., 2002; Phillips et al., 1999). To test if activation of
the mitochondrial pathway is involved in TS-induced apoptosis,Induction of programmed cell death by overexpression
of thymidylate synthase TS-c7 cells were transiently transfected with Bcl-2 or a control
vector, incubated in low serum, and analyzed for apoptosisOverexpression of certain oncogenes has been shown to induce
programmed cell death following the removal of growth factors using an ELISA assay which detects fragmented DNA. Incuba-
tion of the TS-c7 cells in low serum caused a 20- to 25-fold(Evan et al., 1992; Shan and Lee, 1994). Since we have now
shown that TS can behave as an oncogene, we asked whether increase in apoptosis compared to cells grown in 10% serum,
and this was abrogated by transfection of Bcl-2 (Figure 5E).TS overexpression could also promote programmed cell death
upon serum deprivation. TS-overexpressing cell clones TS- c6, Thus, like c-Myc, (Hueber et al., 1997) TS induces apoptosis
via a Bcl-2-dependent mitochondrial pathway.TS-c7, and the control vector clone, V-c1, were grown in media
containing 0.1% or 10% serum and examined after 24 and 48 We also demonstrated that NIH/3T3 cells express both Fas
and Fas ligand and that the expression of these genes was nothr for morphological changes associated with apoptosis. In both
TS-overexpressing cell lines, the majority of cells were either affected by either TS levels or the percent serum used in the
media (data not shown). Unlike the apoptosis induced by c-Myc,detached from the plates or were rounded after 24 hr in 0.1%
serum, displaying cytoplasmic blebs characteristic of cells un- however, inhibition of Fas-Fas ligand interactions with a soluble
Fas receptor did not inhibit apoptosis induced by serum depriva-dergoing apoptosis (Figure 5A). In contrast, the control cells
grown in 0.1% serum (Figure 5A) and both the TS-expressing tion in the TS-c7 cells (data not shown).
and control cells grown in 10% serum (data not shown) dis-
played normal fibroblast morphology. Thus, the morphological Reduction of TS levels in TS-transformed cells
correlates with anchorage-independent phenotypechanges observed between the TS-overexpressing and the
control cells grown in 0.1% serum (Figure 5A) suggest the induc- To examine whether downmodulation of TS may play a role in
regulating the proliferation of transformed cells, we used antion of programmed cell death in the TS-overexpressing cells.
To confirm whether TS-overexpressing cells underwent pro- RNAi strategy to decrease TS expression in TS-transformed
cells. Duplex 21-mer synthetic RNA oligonucleotides directedgrammed cell death, we performed an in situ TUNEL assay
using TS-overexpressing or vector control cells that were grown against a portion of the TS gene were used to modulate TS
levels, while RNA oligonucleotide directed against GAPDH wasfor 24 hr in 0.1%, 1%, and 10% serum containing medium. We
demonstrate that the TS-overexpressing cells grown in 0.1% used as control. Each of these annealed RNA oligonucleotides
was transfected into the TS-transformed cell line TS-c7, andserum-containing medium exhibited 6- to 10-fold induction of
apoptosis as compared to the empty vector control cells (Figure their effects on TS protein levels were compared with mock-
transfected cells by immunoblot analysis at 72 hr posttransfec-5B). In contrast, no apoptosis was detected in the TS-overex-
pressing cells or the control cells grown in 10% serum (Figure tion. We found that RNAi directed against TS reduced the levels
of TS protein in TS-c7 cells but had no effect on actin levels5C). DAPI staining showed that a similar number of TS-c6 and
V-c1 control cells were examined in the indicated visual fields (Figure 6A). In addition, siRNA directed against GAPDH and the
mock transfection did not alter TS expression (Figure 6A).(Figure 5B, lower panel). In addition, TUNEL assays performed
on cells grown in 1% serum containing medium did not show To determine whether the siRNA-mediated reduction in TS
levels was associated with a decrease in the ability of TS-trans-a significant amount of apoptosis in either the control or TS-
overexpressing cells (Figure 5C). We have shown that removal formed cells to form colonies in soft agar, we transfected TS-
c7 cells with duplex synthetic siRNA directed against TS alongof serum from growth medium resulted in apoptosis with DNA
fragmentation in 51% of TS-c6 and 35% of TS-c7 as compared with the following controls: (1) GAPDH control (GAPDH-C), (2)
unrelated sequences from human Mastermine ortholog (hMAM),to 6% in the control cultures as measured by the TUNEL assay
(Figure 5C). and (3) mock transfection. At 24 hr posttransfection, the cells
were placed in soft agar, and colony formations were scoredTo further confirm that the observed apoptotic phenotype
in the TS-overexpressing cell lines was a consequence of cas- 11 days after inoculation. We observed that siRNA directed
against TS resulted in a significant decrease in colony formationpase-mediated programmed cell death and not due to a non-
specific event, we studied caspase activation in TS-induced in TS-c7 cells (Figure 6B). There was at least a 4-fold reduction
in colony formation seen in TS-c7 cells transfected with siRNAcell death. The proteolytic cleavage of the 116 kDa poly (ADP-
ribose) polymerase to an 85 kDa species is a hallmark of caspase directed against TS as compared to the control siRNas.
Since the siRNA results suggested that a reduction in TS3-mediated apoptosis (Lazebnik et al., 1994). We observed that
the 116 kDa PARP was predominant in each of the TS-overex- levels may decrease the efficiency of transformed cells to form
colonies in soft agar, we examined whether TS-c1, a TS-trans-pressing clones until 8 hr following serum deprivation (Figure
5D, lanes 5–12), which was approximately 16 hr before morpho- fected line that expressed 7-fold less TS than TS-c7 (Figure 2,
lanes 3 and 9), would also show a reduction of anchorage-logical changes were detected by light microscopy. By 24 hr,
most of the protein was cleaved in the TS-c6 clone, and 50% independent growth. We compared growth in soft agar between
these two cell lines and found a 6-fold decrease in colony forma-of protein was cleaved in the TS-c7 cells. The cleavage was
dependent on TS overexpression, as serum-starved control tion in soft agar in TS-c1 cells as compared to TS-c7 cells
346 CANCER CELL : APRIL 2004
A R T I C L E
Figure 5. Programmed cell death in thymidylate synthase-transformed cells
A: TS-overexpressing clone (TS-c6) and vector alone transfected cells (V-c1) grown in 0.1% serum.
B: TUNEL assay of TS overexpressing cells and control vector alone cells grown in 10% serum or 0.1% serum for 24 hr. FITC-labeled DNA (upper panel) and
DAPI staining (lower panel) for each cell line.
C: Quantification of apoptotic cells in TS-overexpressing clones (TS-c6 and TS-c7) grown for 24 hr in 10%, 1%, or 0.1% FBS. Results shown are mean  SD of
3 to 6 experiments.
D: Time course of proteolytic cleavage by the poly (ADP-ribose) polymerase (PARP) in TS-c6 and TS-c7 cell grown in 0.1% serum as compared to vector
alone clone V-c1. Arrows depict the 116 kDa PARP and the cleaved 85 kDa PARP protein detected with anti-PARP.
E: TS-c7 cells were transiently transfected with Bcl-2 or a control vector, and the cells were cultured in 10% or 0.1% serum. Apoptosis was quantitated using
an Elisa assay that measured fragmented DNA. The results are presented as the increase in apoptosis seen in low serum (apoptosis index  apoptosis in
0.1% serum/apoptosis in 10% serum). The results represent the mean increase in apoptosis for three experiments  SE. The immunoblot on the bottom panel
shows expression of Bcl-2 for a representative experiment. Tubulin is shown as a loading control.
(Figure 6C). In addition, we established a tetrocyclin-inducible under the control of the Tet-inducible promoter, and a TS induc-
ible clone was isolated and designated as TS/Tet-c1. We foundoverexpression system for TS and asked whether repressing
TS expression would affect the anchorage-independent pheno- that TS/Tet-c1 cells grew in agar with high efficiency (4.8%
efficiency) when TS expression was induced, while the additiontype. NIH/3T3 cells were transfected with a TS expression vector
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et al., 2003; Suzuki et al., 1999). Over the past decade, several
studies have also suggested a possible link of TS gene expres-
sion with cell cycle regulation and cell proliferation. These re-
ports have associated RB growth suppressor function with its
ability to repress the transcriptional activation of E2F target
genes (Harbour and Dean, 2000), which include a wide variety
of metabolic enzymes such as TS, DHFR, and TK (DeGregori
et al., 1995; Dyson, 1998; Helin, 1998). Consistent with the
model that E2F can regulate the expression of these enzymes,
it has been shown that ectopic expression of E2F-1 can stimu-
late the expression of TS in quiescent cells (Johnson et al., 1993)
and that Rb(/) MEF cells overproduce TS protein (Angus et
al., 2002). This suggests that a specific role for RB might be to
inhibit DNA synthesis (Angus et al., 2002) and that, conversely,
overproduction of TS by deregulated RB could participate in
aberrant stimulation of DNA synthesis that might facilitate pro-
gression to a full neoplastic phenotype. We have now tested if
ectopic overexpression of TS could directly act as a trans-
forming agent. In this report, we have demonstrated that cells
that overexpress TS acquire a transformed phenotype scored
by foci formation, growth in soft agar, and the ability to form
tumors in nude mice. While the quantitative efficiency of these
parameters for tumorigenicity is less pronounced than that mea-
Figure 6. Decrease of TS expression results in the inhibition of anchorage- sured for activated protooncogenes such as H-ras, c-myc, or
independent phenotype v-src, our results nevertheless show that catalytically active TS
A: Immunoblot analysis of TS and actin expression in TS-c7 cells 72 hr following exhibits oncogenic potential, and its transformation efficiencies
transfection with siRNA directed against TS, GAPDH, or mock transfection.
are comparable to those previously reported for other trans-B: siRNA directed against TS results in reduction of anchorage-independent
forming genes such as STAT3 or Notch 2 (Bromberg et al., 1999;growth. TS-c7 cells transfected with siRNA directed to TS, GAPDH control
(GAP-C), human Mastermind ortholog (hMAM), or mock transfection were Capobianco et al., 1997). In addition, we have demonstrated a
plated in soft agar 24 hr posttransfection and scored for colony growth at direct association of elevated TS levels with anchorage-inde-
11 days. The results represent the mean of clonal growth in soft agar from pendent phenotype by (1) using a Tet-inducible system, (2)3 to 6 dishes inoculated in two independent experiments.
siRNA directed against TS, and (3) comparison of transfectedC: Comparison of soft agar growth between high (TS-c7) and low (TS-c1)
TS-expressing cell lines. The results represent the mean of clonal colony clones with high and low TS expression.
growth in soft agar from 6 dishes inoculated in two independent experi- To establish whether the delay in tumor formation was con-
ments. sistent with the requirement for additional somatic mutational
D: Tet-inducible induction of TS expression in TS/Tet-c1 cells results in an
events, we have analyzed the p53 and RB suppressor genesincrease of anchorage-independent growth. The immunoblot on the bot-
by protein immunoblot analysis and found low-level, full-lengthtom panel shows TS expression in the absence of dexocyclin (DOXY) and
TS repression in presence of the drug (	DOXY). The results represent the wild-type p53 signal and a wild-type RB migration pattern in
mean of clonal colony growth in soft agar from 6 dishes inoculated in two extracts from TS-overexpressing xenograft tumors. While these
independent experiments. results are consistent with prior studies that have failed to detect
a relationship between p53 and TS levels in colon cancer biop-
sies (Johnston et al., 2003), additional defects in oncogene and
tumor suppressor pathways remain to be defined in these tumorof doxycyclin that repressed gene expression resulted in a de-
cells.crease of agar growth (1.4% efficiency) (Figure 6D). Taken to-
To confirm a link between TS activity and transformation,gether, these results suggest that decreasing TS expression
we overexpressed two plasmids, each carrying a different singleby three distinct methods results in a reduction of anchorage-
point mutation located within the highly conserved and catalyti-independent cell growth.
cally essential Arg50-loop of TS (Schiffer et al., 1995). This loop
forms a bridge between the dUMP substrate and the CH2CH4-Discussion
folate cofactor and the C-terminal domain of the enzyme. Muta-
tions between residues 47 to 52 disrupt the hydrogen bondingTS has long been identified as a potential target for cancer
network within the Arg50 loop that mediates dUMP binding andchemotherapeutic agents because of the essential role it plays
also affects the ability of TS subunits to homodimerize (Voellerin the de novo synthesis of thymidylate. In addition, the level
et al., 2002). We showed that the Arg50Cys and Thr51Ala mutantof TS protein expression has been shown to predict for the
TS plasmids express a stable protein species that results inoverall survival of patients with colon cancer as well as for
loss of catalytic activity. We also showed that in contrast topossible resistance to chemotherapeutic agents, such as TS
wild-type TS, the inactive TS mutants could not transform cellsinhibitors (Chu and Allegra, 1996; Johnston et al., 1995; Peters
in culture and that overexpression of Arg50Cys and Thr51Alaet al., 1995). High levels of TS have also been correlated with
TS mutants did not result in (1) foci formation, (2) growth inpoor prognosis in patients with ovarian cancer, rectal cancer,
semisolid medium, or (3) tumor formation in nude mice. Theseand non-small cell lung carcinoma (Edler et al., 2000; Mizutani
et al., 2003; Nomura et al., 2002; Pestalozzi et al., 1997; Shintani data demonstrate that the TS induction of a neoplastic pheno-
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type requires the catalytic activity of the enzyme. While it is not apoptotic cell death pathway support the use of TS as a potential
surprising that the regulation of DNA synthesis might play a biomarker (Chu et al., 2003) in cancer, and may provide further
role in cellular transformation, the present work demonstrates rationale for the development of effective antitumor agents.
a direct link between the DNA synthetic enzyme apparatus and
Experimental proceduresthe establishment of neoplastic phenotype.
Interestingly, it was previously shown that overexpression
Plasmidsof an enzyme that is also essential for DNA synthesis and repair,
Plasmid pCIneo-TS was constructed by PCR amplification of the plasmidribonucleotide reductase, also predisposes cells to the acquisi-
pcEHTS (ref) using the following primers: sense 5TTT TCT AGA CCG CCC
tion of a malignant phenotype. Altered expression of the R2 GCC GCG CCA TGC CTG TGG CCG GCT CGG 3 and antisense 5TTT
component of ribonucleotide reductase cooperates with ras and TCT AGA ACC CTA AAC AGC CAT TTC CAT3, which amplified the region
other oncogenes in the mechanism of neoplastic progression from 146 bp from the ATG site to 944 bp. PCR fragments were subcloned
(Fan et al., 1996, 1998). In contrast, it was shown that the R1 into the Xba I site of the pCIneo vector (Invitrogen) generating the pCIneo-
TS expression plasmid. For construction of pcDNA3.1zeo-TS, the 958 bpsubunit of ribonucleotide reductase has malignancy sup-
Xba I DNA fragment excised from pCIneo-TS was subcloned into the mam-pressing activity when overexpressed in ras-transformed fibro-
malian expression vector, pcDNA3.1 zeo (	) (Invitrogen). The mutant plas-blast (Fan et al., 1997). These results suggest that ribonucleotide
mids (gift from D. Banerjee and J. Bertino) were subcloned into the HindIII/reductase, in addition to DNA synthesis and repair, can partici-
Xho site of the pcDNA3.1 zeo (	) vector. Nucleotide sequences were ob-pate in other critical cellular functions, and that the alteration
tained to confirm the presence of Arg50Cys and Th51Ala mutations. Plasmid
in the balance of R1 and R2 levels may affect transformation, Tet-TS was constructed by subcloning a blunt-ended 948 bp HindIII/PmeI
tumorigenicity, and metastatic potential. DNA fragment of TS into the blunt-ended BamHI site of the tetracycline-
The TS-dependent conversion of dUMP to TMP is an essen- inducible vector, Ec1514A (Li et al., 1996). Bcl-2 expression plasmid was
tial step for providing the necessary dTTP components required cloned in pcDNA 3 (Invitrogen) and was a gift from M. Blagosklonny.
for DNA replication and for maintaining a proper nucleotide
Cell culture, transfections, foci assays, and growth analysisbalance within the cells. RB-mediated cell cycle arrest, which
NIH/3T3 and RK3E cells were maintained in Dulbelcco’s modified Eagle’sresults in a decrease of TS expression, was shown to be associ-
medium (DMEM) supplemented with 10% fetal calf serum, 1% glutamine,ated with dTTP and dATP depletion, resulting in a higher per-
and 1% penicillin/streptomycin. NIH/3T3 cells were transfected with 10 gcentage of dCTP in the total nucleotide pool (Angus et al., 2002).
of plasmids by calcium phosphate precipitation as previously describedThis data suggested that one mechanism by which the RB
(Reinhold et al., 1995). Cells from each transfection were split 1:3 and grown
tumor suppressor pathway may regulate DNA replication is by for 14 days in 800 g/ml of zeocin or 600 g/ml of G418 selection medium.
controlling the levels and ratios of intracellular nucleotide pools Foci assays were performed at passage 3 or passage 8 by plating 5  105
(Angus et al., 2002). Thus, overexpression of TS might also be cells per 100 mm petri dishes in zeocin selection, and at passage 1 when
predicted to generate an imbalance of dNTP pools that may plated in G418-containing medium. Cells were incubated for 5–6 weeks,
fixed with 10% methanol, 10% acidic acid solution, and stained with 20%have multifactorial effects on cell homeostasis, including an
ethanol, 0.4% crystal violet for 5 min. For generating growth curves, NIH/increase in the mutational rates or an impairment of DNA repair
3T3 cells were plated at 2  105 cells per 100 mm dish and counted inmechanisms (Bradley and Sharkey, 1978; Davidson and Kauf-
triplicate using a Beckman Coulter Counter. RK3E cells were transfectedman, 1978; Meuth, 1981, 1989).
with 15 g of plasmids by Fugene 6 as described by the manufacturerAs described for other oncogenes (Hueber et al., 1997), we
(Roche Molecular). Cells from each transfection were split by plating 1.4 
have also shown that TS-transformed cells undergo apoptotic
106 cells per 100 mm dish and grown for 10 days in 100 g/ml of zeocin.
cell death following removal of serum from their growth medium. Foci assays were performed at passage 2 by plating 1.5  106 cells per 100
Serum deprivation, however, not only removes growth factors, mm petri dishes in zeocin selection. Cells were incubated for 3 weeks and
but also removes the supply of thymidine that is required to fixed as described above. For isolation of single cell clones containing Tet-
maintain the nucleotide pool balance and DNA synthesis. Since inducible TS gene, NIH/3T3 cells were transfected with 15 g of Tet-TS
plasmid using Fugene 6 and single cell clones were selected in 600 g/mlremoval of thymidine has been previously shown to result in
of G418. Cells were expanded in medium with serum containing traceapoptosis, referred to as “thymineless death” (Houghton et al.,
amounts of tetrocyclin and then switched to a medium supplemented with1994), it was possible that overexpression of TS might protect
tetracycline-free fetal calf serum (BD Biosciences, Palo Alto, CA). For softthese cells from undergoing apoptotic cell death. In contrast,
agar analysis, cells were grown for 48 hr in the presence or absence of 2however, we observed that TS overexpression resulted in the
g/ml doxycyline in medium containing a tetracycline-free fetal calf serum.
induction of apoptosis, as measured by PARP cleavage, which
occurred as early as 8 hr after serum removal, and by TUNEL Cellular extract preparation, antibodies, and Western blot analysis
assay that was measured 24 hr after serum deprivation. Thus, Whole cell extracts were prepared as previously described (Niklinski et al.,
high levels of TS may lead to an accumulation of genetic alter- 2000). Cells were lysed in EBC buffer (50 mM Tris [pH 7.5], 200 mM NaCl,
ations in the genome due to direct or indirect dNTP imbalance 50 mM NaF, 5 mM EDTA, 0.1% Nonidet P-40 5 mM Mg2Cl) supplemented
with 0.5 mM dithiothreitol, 1 mM phenyl-methylsulfonyl fluoride, and leupep-that can result in transformed phenotype, and in enhanced sus-
tin and aprotenin (10 g/ml each). One hundred micrograms of proteinceptibility to apoptotic cell death upon serum removal. The
extract was resolved by sodium dodecyl sulfate-polyacrylamide gel electro-observation that Bcl-2 can inhibit TS-induced apoptosis in low
phoresis (SDS-PAGE), transferred to nitrocellulose filters, and immunoblot-serum suggests a role for activation of mitochondrial pathway
ted with anti-TS antibody (clone TS-106) in a 1:100 dilution as previouslyin these cells. The mechanism that underlines the ability of
described (Alexandrova et al., 1995; Behan et al., 1998). For analysis of
ectopic TS overexpression to induce apoptotic cell death and
apoptosis by PARP cleavage, cells were grown in 0.1% serum, and both
how TS activates the mitochondrial apoptosis pathway and the attached and detached cells were used for cell extract preparation. The anti-
neoplastic transformation remains to be defined. In addition, the PARP antibody (H-250) and the Bcl-2 antibody (100) were obtained from
observations that ectopic TS could participate in tumorigenicity Santa Cruz Biotechnology and both used in a 1:200 dilution. The -Tubulin
antibody (clone DM1A) was obtained from Sigma and used in 1:500 dilution.and that TS-overexpressing cells could be susceptible to an
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